Facebook Pixel PROSOLV® 730: Directly compressible carrier for lipophilic ingredients | Express Pharma - health - Read this story on Magzter.com

Try GOLD - Free

PROSOLV® 730: Directly compressible carrier for lipophilic ingredients

Express Pharma

|

November 2025

Nearly 90 % of molecules in the discovery pipeline and 40 % of drugs with market approval are poorly water soluble. Poor aqueous solubility can lead to low bioavailability resulting in insufficient plasma levels. Oil-based preparations of these APIs, as well as oily APIs in general, present challenges in terms of solid dosage form manufacturing. PROSOLV® 730 was designed to provide a solution to the formulation of BCS class II and IV APIs. It enables the formulation of lipidic APIs or API-loaded lipid systems by facilitating the adsorption of oil, creating a free-flowing, compactible system that can be further formulated. PROSOLV® 730 is a co-processed, high-functionality excipient comprising MCC SILICA COPOVIDONE

- Mr. Suyesh Kale

Nearly 90% of molecules in the discovery pipeline and 40% of drugs with market approval are poorly water soluble.

Poor aqueous solubility can lead to low bioavailability resulting in insufficient plasma levels.

Oil-based preparations of these APIs, as well as oily APIs in general, present challenges in terms of solid dosage form manufacturing.

PROSOLVⓇ 730 was designed to provide a solution to the formulation of BCS class II and IV APIs. It enables the formulation of lipidic APIs or APIloaded lipid systems by facilitating the adsorption of oil, creating a free-flowing, compactible system that can be further formulated.

PROSOLV® 730 is a coprocessed, high-functionality excipient comprising MCC SILICA COPOVIDONE

Specific surface area

PROSOLV 730 presents a 70 plus times greater specific surface area than Microcrystalline Cellulose.

Physical Properties of PROSOLV® 730

  • High oil binding capacity

  • White, free-flowing powder

  • Chemically inert

  • Non-soluble

  • Excellent compactability

  • Enhanced lubrication efficiency

  • Improved blending properties

  • Over 70 times greater specific surface area than regular Microcrystalline Cellulose (MCC)

  • Coprocessed excipient with no chemical bonding between ingredients

MORE STORIES FROM Express Pharma

Express Pharma

Express Pharma

Standardisation vs customisation in single-use systems for bioprocessing: What do biopharma companies need?

Priyabrata Pattnaik, CEO, Ami Polymer highlights the balance between standardisation and customisation in single - use systems in biopharma manufacturing

time to read

5 mins

May 2026

Express Pharma

Express Pharma

Ensuring Pharma compliance with testo data measurement technology

Due to the crucial necessity and its direct impact on human health and welfare, Pharma is probably the most important and critical sector among others.

time to read

3 mins

May 2026

Express Pharma

Express Pharma

China+1 moment for pharma: How India can convert opportunity into long-term contracts

Manish Jain, Director, Naprod Life Sciences explains how India must move beyond cost advantage to lead with reliability, quality, and transparency to reshape global pharma supply chains and position itself as a trusted, long-term partner

time to read

3 mins

May 2026

Express Pharma

Express Pharma

Beyond scale: Rethinking new frontiers in building excellence

At the Injectable Innovations Conclave 2026, hosted by Express Pharma, industry leaders examined the trends, technologies and strategies shaping the next phase of injectable growth, reports

time to read

10 mins

May 2026

Express Pharma

Express Pharma

Waters receives CE mark for BD BACTEC FXI Culture System under EU IVDR

Next-generation blood culture system records ~3-hour faster detection time and introduces automated blood volume measurement

time to read

2 mins

May 2026

Express Pharma

Express Pharma

JNPC: Carrying forward a 20-year old legacy

Billed as India's first bulk drug, chemicals and allied manufacturing parks and one of the most successful public-private partnerships (PPP) in the pharma sector, the Jawaharlal Nehru Pharma City (JNPC), also known as Visakha Pharma City, was set up in February 2005 as a PPP initiative by the Govt of Andhra Pradesh (GoAP) through its nodal agency Andhra Pradesh Industrial Infrastructure Corporation (APIIC) with the Ramky Group on a Build-Own-Operate (BOO) basis for 20 years.

time to read

3 mins

May 2026

Express Pharma

Express Pharma

Romaco's sustainable blister packaging line at interpack

At this year's interpack, the Romaco Group will present its sustainable Unity 600 high-speed blister packaging line, featuring – for the first time – the PF 75 stretch bander.

time to read

6 mins

May 2026

Express Pharma

Express Pharma

Even drug-resistant cancer targets can be tackled with the right design strategy

Dr Bajarang Kumbhar, Assistant Professor, Sunandan Divatia School of Science, NMIMS Mumbai, explains how Al-driven computational biology is reshaping CAR-T therapy and highlights how these approaches help cut drug discovery timelines and improve targeted, personalised cancer treatment, in an interaction with Kalyani Sharma

time to read

7 mins

May 2026

Express Pharma

Express Pharma

Navigating legal and regulatory landscape of GLP-1 drugs in India

GLP-1 drugs are drawing sharp regulatory and legal scrutiny, especially with generics entering post-patent expiry. They emphasise that navigating IP, compliance, and marketing rules is now critical for stakeholders

time to read

5 mins

May 2026

Express Pharma

Express Pharma

From back office to brain trust: How life sciences GCCs are redefining leadership hiring in India

Sai Gandhi, Partner, Positive Moves points out that life sciences GCCs in India are moving from support roles to driving core innovation and global strategy. In turn, leadership hiring is shifting toward cross-functional, globally savvy leaders who can deliver enterprise-wide impact

time to read

4 mins

May 2026

Listen

Translate

Share

-
+

Change font size